Does Blue Cross Blue Shield cover Zepbound or Wegovy?
Last updated
It depends on your Blue company and plan; several ended weight-loss coverage.
If it is not covered: the lowest cash prices now

Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Without insurance: compounded semaglutide on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before
It depends on your Blue company and plan; several ended weight-loss coverage. Blue Cross Blue Shield of Massachusetts ended coverage of GLP-1s for weight loss at each plan's renewal from January 1, 2026, keeping coverage for type 2 diabetes. In its words: "We’ve made the decision to end coverage for GLP-1 medications, except for type 2 diabetes. This change will take effect upon your plan renewal, starting January 1, 2026." (Blue Cross Blue Shield of Massachusetts member page, We've changed our GLP-1 coverage, bluecrossma.org/glp-1-coverage-update, Jan 1, 2026, read Nov 17, 2026). At Blue Cross Blue Shield of Massachusetts only employers with more than 100 employees can keep Wegovy and Zepbound coverage; smaller groups and direct-pay members lost it at renewal, and the exclusion cannot be appealed. In its words: "If your company has more than 100 employees, your employer will have the option to continue coverage. If they choose not to, upon plan renewal starting January 1, 2026, Wegovy, Saxenda, and Zepbound will no longer be covered, even if you’re currently using them." (Blue Cross Blue Shield of Massachusetts member page, We've changed our GLP-1 coverage, bluecrossma.org/glp-1-coverage-update, Jan 1, 2026, read Nov 17, 2026). Blue Cross Blue Shield of Michigan and Blue Care Network ended weight-loss GLP-1 coverage for fully insured large group commercial members from January 1, 2025 (or the group's renewal date); self-funded groups could keep covering them. In its words: "Coverage for GLP-1 weight loss drugs for fully-insured large group commercial members will end starting Jan. 1, 2025. For group members with a plan renewal date other than Jan. 1, the coverage will end on the renewal date." (Blue Cross Blue Shield of Michigan and BCN provider alert, Changes coming for select weight loss drugs for some commercial members, posted June 6, 2024, updated July 30, 2024, providerinfo.bcbsm.com, read Nov 17, 2026). Blue Cross and Blue Shield of Vermont made Wegovy, Zepbound and Saxenda for weight loss a benefit exclusion from January 1, 2026, but keeps covering Wegovy with prior approval for adults with cardiovascular disease and obesity. In its words: "Beginning January 1, 2026, Blue Cross and Blue Shield of Vermont will no longer cover prescription drugs containing Glucagon-Like Peptide-1 (GLP-1) receptor agonists that are FDA-approved for weight loss, including Wegovy®, Zepbound® and Saxenda®. This will be a benefit exclusion." (Blue Cross and Blue Shield of Vermont, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 17, 2026).
Each Blue Cross Blue Shield company's own rule
- Does Florida Blue cover Zepbound or Wegovy? Only if your employer bought weight-loss coverage.
- Does Blue Cross and Blue Shield of Texas cover Zepbound or Wegovy? Not a standard benefit; some self-funded employer plans add it.
- Does Blue Cross NC cover Zepbound or Wegovy? Not a standard benefit; self-funded employer plans can add it.
- Does Highmark cover Zepbound or Wegovy? Only if your plan includes the anti-obesity benefit.
- Does CareFirst cover Zepbound or Wegovy? Only if your plan includes weight loss medications.
- Does Independence Blue Cross cover Zepbound or Wegovy? Not on fully insured plans since 2025; employer weight-loss benefits still cover.
- Does Blue Shield of California cover Zepbound or Wegovy? It depends on the plan since 2026; some cover only at a BMI of 40.
- Does Horizon Blue Cross Blue Shield of New Jersey cover Zepbound or Wegovy? Not under select Horizon plans since Oct 1, 2026, except for MASH.
- Does Premera Blue Cross cover Zepbound or Wegovy? Only when your employer elects the benefit.
- Does Regence cover Zepbound or Wegovy? Only if your benefit contract includes weight-loss drugs.
- Does Excellus BlueCross BlueShield cover Zepbound or Wegovy? Only if your contract covers them; never Zepbound vials or KwikPens.
- Does Wellmark cover Zepbound or Wegovy? A standard exclusion for most plans; covered where the plan adds it.
Blue Cross Blue Shield, Zepbound and Wegovy: common questions
Does Blue Cross Blue Shield cover Zepbound for weight loss?
It depends on your Blue company and plan; several ended weight-loss coverage. Blue Cross Blue Shield of Massachusetts ended coverage of GLP-1s for weight loss at each plan's renewal from January 1, 2026, keeping coverage for type 2 diabetes. In its words: "We’ve made the decision to end coverage for GLP-1 medications, except for type 2 diabetes. This change will take effect upon your plan renewal, starting January 1, 2026." (Blue Cross Blue Shield of Massachusetts member page, We've changed our GLP-1 coverage, bluecrossma.org/glp-1-coverage-update, Jan 1, 2026, read Nov 17, 2026). At Blue Cross Blue Shield of Massachusetts only employers with more than 100 employees can keep Wegovy and Zepbound coverage; smaller groups and direct-pay members lost it at renewal, and the exclusion cannot be appealed. In its words: "If your company has more than 100 employees, your employer will have the option to continue coverage. If they choose not to, upon plan renewal starting January 1, 2026, Wegovy, Saxenda, and Zepbound will no longer be covered, even if you’re currently using them." (Blue Cross Blue Shield of Massachusetts member page, We've changed our GLP-1 coverage, bluecrossma.org/glp-1-coverage-update, Jan 1, 2026, read Nov 17, 2026). Blue Cross Blue Shield of Michigan and Blue Care Network ended weight-loss GLP-1 coverage for fully insured large group commercial members from January 1, 2025 (or the group's renewal date); self-funded groups could keep covering them. In its words: "Coverage for GLP-1 weight loss drugs for fully-insured large group commercial members will end starting Jan. 1, 2025. For group members with a plan renewal date other than Jan. 1, the coverage will end on the renewal date." (Blue Cross Blue Shield of Michigan and BCN provider alert, Changes coming for select weight loss drugs for some commercial members, posted June 6, 2024, updated July 30, 2024, providerinfo.bcbsm.com, read Nov 17, 2026). Blue Cross and Blue Shield of Vermont made Wegovy, Zepbound and Saxenda for weight loss a benefit exclusion from January 1, 2026, but keeps covering Wegovy with prior approval for adults with cardiovascular disease and obesity. In its words: "Beginning January 1, 2026, Blue Cross and Blue Shield of Vermont will no longer cover prescription drugs containing Glucagon-Like Peptide-1 (GLP-1) receptor agonists that are FDA-approved for weight loss, including Wegovy®, Zepbound® and Saxenda®. This will be a benefit exclusion." (Blue Cross and Blue Shield of Vermont, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 17, 2026). Zepbound not covered: the cash price at your dose
Does Blue Cross Blue Shield cover Wegovy for weight loss?
It depends on your Blue company and plan; several ended weight-loss coverage. Blue Cross Blue Shield of Massachusetts ended coverage of GLP-1s for weight loss at each plan's renewal from January 1, 2026, keeping coverage for type 2 diabetes. In its words: "We’ve made the decision to end coverage for GLP-1 medications, except for type 2 diabetes. This change will take effect upon your plan renewal, starting January 1, 2026." (Blue Cross Blue Shield of Massachusetts member page, We've changed our GLP-1 coverage, bluecrossma.org/glp-1-coverage-update, Jan 1, 2026, read Nov 17, 2026). At Blue Cross Blue Shield of Massachusetts only employers with more than 100 employees can keep Wegovy and Zepbound coverage; smaller groups and direct-pay members lost it at renewal, and the exclusion cannot be appealed. In its words: "If your company has more than 100 employees, your employer will have the option to continue coverage. If they choose not to, upon plan renewal starting January 1, 2026, Wegovy, Saxenda, and Zepbound will no longer be covered, even if you’re currently using them." (Blue Cross Blue Shield of Massachusetts member page, We've changed our GLP-1 coverage, bluecrossma.org/glp-1-coverage-update, Jan 1, 2026, read Nov 17, 2026). Blue Cross Blue Shield of Michigan and Blue Care Network ended weight-loss GLP-1 coverage for fully insured large group commercial members from January 1, 2025 (or the group's renewal date); self-funded groups could keep covering them. In its words: "Coverage for GLP-1 weight loss drugs for fully-insured large group commercial members will end starting Jan. 1, 2025. For group members with a plan renewal date other than Jan. 1, the coverage will end on the renewal date." (Blue Cross Blue Shield of Michigan and BCN provider alert, Changes coming for select weight loss drugs for some commercial members, posted June 6, 2024, updated July 30, 2024, providerinfo.bcbsm.com, read Nov 17, 2026). Blue Cross and Blue Shield of Vermont made Wegovy, Zepbound and Saxenda for weight loss a benefit exclusion from January 1, 2026, but keeps covering Wegovy with prior approval for adults with cardiovascular disease and obesity. In its words: "Beginning January 1, 2026, Blue Cross and Blue Shield of Vermont will no longer cover prescription drugs containing Glucagon-Like Peptide-1 (GLP-1) receptor agonists that are FDA-approved for weight loss, including Wegovy®, Zepbound® and Saxenda®. This will be a benefit exclusion." (Blue Cross and Blue Shield of Vermont, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 17, 2026). Wegovy not covered: the cash price at your dose
Does Blue Cross Blue Shield cover Wegovy for heart disease?
Blue Cross and Blue Shield of Vermont's FAQ says Wegovy stays covered with prior approval when prescribed to reduce cardiovascular risk in adults with cardiovascular disease and obesity. In its words: "You are an adult with diagnosed cardiovascular disease and obesity, and your provider prescribes Wegovy® to reduce your risk of certain cardiovascular events." (Blue Cross and Blue Shield of Vermont, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 17, 2026).
What do Zepbound and Wegovy cost if Blue Cross Blue Shield does not cover them?
Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 11, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). Every GLP-1's cash price without insurance
Does Medicaid cover Zepbound or Wegovy?
It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.